Evidence map›Paper›PMID 40823536›Full record

ArticleGut microbes reports2025

Gut microbial dysbiosis activates the classical complement pathway in a short-term morphine treatment model.

Nicolas Vitari, Richa Jalodia, Junyi Tao, Udhghatri Kolli, Salma Singh, Lily V Rodriguez, Umakant Sharma, Sabita Roy

Abstract read
In one paragraph

Article in Gut microbes reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nicolas VitariDepartment of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, US.
Richa JalodiaDepartment of Surgery, University of Miami Miller School of Medicine, Miami, US.
Junyi TaoDepartment of Surgery, University of Miami Miller School of Medicine, Miami, US.
Udhghatri KolliDepartment of Surgery, University of Miami Miller School of Medicine, Miami, US.
Salma SinghDepartment of Surgery, University of Miami Miller School of Medicine, Miami, US.
Lily V RodriguezDepartment of Surgery, University of Miami Miller School of Medicine, Miami, US.
Umakant SharmaDepartment of Surgery, University of Miami Miller School of Medicine, Miami, US.
Sabita RoyDepartment of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, US.

Funding

Role of Microbial dysbiosis and altered metabolomics in the context of Opioid abuse and ART in HIV disease progressionR01DA043252 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ROY, SABITA · 2017 to 2021
$3.0M
Gut microbiota disruption by Morphine and in the context of HIV infection contributes to sustained immune activationR01DA037843 · NIDA · UNIVERSITY OF MINNESOTA · PI JOHNSON, TIMOTHY J, ROY, SABITA · 2014 to 2018
$2.8M
Microbial Dysbiosis and TLR2 Activation Contribute to Immune Activation, Inflammation and HIV Persistence in the Context of Opioid Abuse Despite ART TherapyR01DA044582 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ROY, SABITA · 2017 to 2021
$2.6M
Role of Gut Microbiome- Brain Axis in Modulating CNS Inflammasomes in the Neuropathology Produced by Opioid Exposure and HIV R01DA050542 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ROY, SABITA · 2019 to 2023
$2.5M
Role of Gut Microbiome in HIV/Opioid Induced Peripheral NeuropathyR01DA047089 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI HAO, SHUANGLIN, RAMAKRISHNAN, SUNDARAM · 2018 to 2022
$2.3M
Mechanism underlying Morphine modulation of gut barrier function in the Context oR01DA034582 · NIDA · UNIVERSITY OF MINNESOTA · PI ROY, SABITA · 2013 to 2017
$1.6M
Multidisciplinary Training in Substance Abuse ResearchT32DA045734 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ROY, SABITA · 2019 to 2023
$1.0M
Predoctoral Training in Translational ImmunologyT32AI162624 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Thomas R Malek · 2022 to 2026
$894k
Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infectionR21DA057887 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ROY, SABITA · 2024 to 2025
$439k
NIAID NIH HHS T32 AI162624NIDA NIH HHS R01 DA034582NIDA NIH HHS R01 DA037843NIDA NIH HHS R01 DA043252NIDA NIH HHS R01 DA044582NIDA NIH HHS R01 DA047089NIDA NIH HHS R01 DA050542NIDA NIH HHS R21 DA057887NIDA NIH HHS T32 DA045734
6 · The paper itself

Abstract

Antibodies play an essential role in preserving intestinal homeostasis in healthy and dysbiotic states. Recent studies demonstrate that a microbiome-dependent intestine-specific complement system maintains intestinal homeostasis. Morphine induces microbial dysbiosis within hours of administration characterized by the expansion of pathogenic bacteria with a concurrent decrease in commensal bacteria. A murine model of short-term morphine treatment was used to provide insights into the early immune processes during microbial dysbiosis. Within 24 h, morphine treatment upregulates the expression of classical complement pathway genes in intestinal tissue, with a concurrent increase in the complement proteins C1q and C3 in the ileal luminal content. Importantly, a parallel increase in the concentration of complement-activating antibodies IgM and IgG is observed in the ileal luminal content at 24 h. The increased concentration of complement proteins and antibodies are dependent on the microbiome, as microbial depletion prior to morphine treatment abolishes this increase. Finally, intestinal infiltration and activation of neutrophils is observed concurrent with microbial dysbiosis. This study demonstrates rapid microbiome-dependent intestinal recruitment of complement machinery during microbial dysbiosis. Together, these data confirm the relationship between intestinal complement and the microbiome and shows that the classical complement system is activated to protect the host during microbial dysbiosis.

Indexed as

classical complement pathwayIgG3IgMmicrobiomemorphine

Identifiers

PMID40823536
PMCPMC12352340

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.